<?xml version="1.0" encoding="UTF-8"?>
<p id="para0010">AT1R antagonists or vitamin D or a combination could prove to be beneficial in COVID-19 patients who are prone to have lung complications. However, the role of these drugs in patients who do not develop any lung injury is unclear. As there are no available proven treatments for COVID-19 infection, the possibility of using drugs like AT1R antagonists and vitamin D to prevent or lessen the severity of acute lung complications of COVID-19 needs investigation. These widely available, inexpensive drugs may help alleviate the massive burden of managing severe COVID-19 cases.</p>
